NovoLog Mix 70/30

Product NDC: 0169-3696
11-digit product format: 001693696
Labeler code: 0169
Product ID: 0169-3696_ecfd53fb-5887-48df-bc66-c32f8ff0cf67
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: insulin aspart
Dosage form: INJECTION, SUSPENSION
Route: SUBCUTANEOUS
Labeler: Novo Nordisk
Application: BLA021172
Marketing category: BLA
Marketing start: 2002-09-11
Substance: INSULIN ASPART
Active strength: 100 [iU]/mL
Pharmacologic classes: Insulin Analog [EPC], Insulin [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0169-3696	0169-3696-97	D	Discontinued by firm		2026-08-11
excluded package	package	0169-3696	0169-3696-98	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	0169-3696-97	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	0169-3696-98	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	0169-3696-97	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	0169-3696-98	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	0169-3696-97	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	0169-3696-98	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	0169-3696-97	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	0169-3696-98	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	0169-3696-97	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	0169-3696-98	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	0169-3696-97	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	0169-3696-98	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	0169-3696-97	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	0169-3696-98	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	0169-3696-97	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	0169-3696-98	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	0169-3696-97	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	0169-3696-98	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	0169-3696-97	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	0169-3696-98	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	0169-3696-97	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	0169-3696-98	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	0169-3696-97	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	0169-3696-98	`557ba5c1ecfa…`	`9c80585c8c6e…`

Additional Listing Data#

Finished product: Yes
Brand name base: NovoLog Mix 70/30
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
INSULIN ASPART	100 [iU]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
D933668QVX	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
351297	Internal RxNorm lookup
847191	Internal RxNorm lookup
977840	Internal RxNorm lookup
977842	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1861fcee-7673-4afe-a206-08fa05c0add2	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
24eab60a-55c8-40c1-8c86-7ed01a7a8bef	Product name	1	20240227
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
09fb02dd-baf0-4f67-b464-599bf26324b6	Product name	2	20200323
6a6ef80c-37d6-4e02-aa78-fce7b811234e	Product name	2	20200323
91ae268d-ee0f-6988-629d-5065a4376a50	Product name	2	20200323
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0169-3696-19	NovoLog Mix 70/30	3 mL in 1 SYRINGE, PLASTIC	INJECTION, SUSPENSION	3	24
0169-3696-19	NovoLog Mix 70/30	5 in 1 CARTON	INJECTION, SUSPENSION	5	24
0169-3696-90	NovoLog Mix 70/30	3 mL in 1 SYRINGE, PLASTIC	INJECTION, SUSPENSION	3	24
0169-3696-97	NovoLog Mix 70/30	1 in 1 CARTON	INJECTION, SUSPENSION	1	24
0169-3696-97	NovoLog Mix 70/30	3 mL in 1 SYRINGE, PLASTIC	INJECTION, SUSPENSION	3	24
0169-3696-98	NovoLog Mix 70/30	1 in 1 CARTON	INJECTION, SUSPENSION	1	24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0169-3696-19	ML - Milliliter	0169-3696	a4605715-f412-41e5-9897-aa21e6eb9fff	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
INSULIN ASPART	ACTIVE INGREDIENT	D933668QVX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
insulin aspart	ACTIVE MOIETY	D933668QVX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
METACRESOL	INACTIVE INGREDIENT	GGO4Y809LO	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
PHENOL	INACTIVE INGREDIENT	339NCG44TV	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
PROTAMINE SULFATE	INACTIVE INGREDIENT	0DE9724IHC	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	94255I6E2T	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
ZINC	INACTIVE INGREDIENT	J41CSQ7QDS	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	16
INSULIN ASPART	ACTIVE INGREDIENT	D933668QVX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
INSULIN ASPART	ACTIVE MOIETY	D933668QVX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
METACRESOL	INACTIVE INGREDIENT	GGO4Y809LO	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
PHENOL	INACTIVE INGREDIENT	339NCG44TV	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
PROTAMINE SULFATE	INACTIVE INGREDIENT	0DE9724IHC	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	94255I6E2T	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2
ZINC	INACTIVE INGREDIENT	J41CSQ7QDS	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0169-3696	NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]	24	Current NDC, Legacy NDC, 6 package rows	20230315_1861fcee-7673-4afe-a206-08fa05c0add2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NovoLog Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	66da64f7-ca50-47d2-95fa-de37005eef85	2026-05-18	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	5d9f0e10-edb9-4960-bd62-cf406e75bbe7	2026-04-07	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	A-S Medication Solutions	19888a44-b330-462a-864d-338c5893dd63	2026-01-29	Warnings, Adverse reactions	Exact identifier application number: BLA021172
.Insulin Aspart Protamine and Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	14499781-b90e-47d5-a7de-006965439b94	2024-02-22	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	Novo Nordisk Pharma, Inc.	fc94baa4-3606-48bc-a781-9617ab6960ef	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	Novo Nordisk	1861fcee-7673-4afe-a206-08fa05c0add2	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172 ndc (product): 0169-3696

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
021172	Novolog Mix 70/30	insulin aspart protamine and insulin aspart	351(a)	Rx	2026-07-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D933668QVX	INSULIN ASPART	116094-23-6	INSULIN ASPART

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin aspart protamine / insulin aspart 70/30 Injectable Suspension	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977842	NovoLOG Mix 70/30 Injectable Suspension	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	19888a44-b330-462a-864d-338c5893dd63	32
977842	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]	SBD	19888a44-b330-462a-864d-338c5893dd63	32
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension	SCD	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension	SY	19888a44-b330-462a-864d-338c5893dd63	32
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	19888a44-b330-462a-864d-338c5893dd63	32
977842	NovoLog Mix 70/30 Injectable Suspension	SY	19888a44-b330-462a-864d-338c5893dd63	32
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	19888a44-b330-462a-864d-338c5893dd63	32
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	1861fcee-7673-4afe-a206-08fa05c0add2	24
351297	insulin aspart protamine / insulin aspart 70/30 Injectable Suspension	PSN	1861fcee-7673-4afe-a206-08fa05c0add2	24
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	1861fcee-7673-4afe-a206-08fa05c0add2	24
977842	NovoLOG Mix 70/30 Injectable Suspension	PSN	1861fcee-7673-4afe-a206-08fa05c0add2	24
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	1861fcee-7673-4afe-a206-08fa05c0add2	24
977842	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]	SBD	1861fcee-7673-4afe-a206-08fa05c0add2	24
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	1861fcee-7673-4afe-a206-08fa05c0add2	24
351297	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension	SCD	1861fcee-7673-4afe-a206-08fa05c0add2	24
351297	insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension	SY	1861fcee-7673-4afe-a206-08fa05c0add2	24
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	1861fcee-7673-4afe-a206-08fa05c0add2	24
977842	NovoLog Mix 70/30 Injectable Suspension	SY	1861fcee-7673-4afe-a206-08fa05c0add2	24
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	1861fcee-7673-4afe-a206-08fa05c0add2	24
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	66da64f7-ca50-47d2-95fa-de37005eef85	14
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	66da64f7-ca50-47d2-95fa-de37005eef85	14
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	66da64f7-ca50-47d2-95fa-de37005eef85	14
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	66da64f7-ca50-47d2-95fa-de37005eef85	14
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	66da64f7-ca50-47d2-95fa-de37005eef85	14
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	66da64f7-ca50-47d2-95fa-de37005eef85	14
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	ead74453-dd15-4836-8ad6-5b14ac168d02	6
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	ead74453-dd15-4836-8ad6-5b14ac168d02	6
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	ead74453-dd15-4836-8ad6-5b14ac168d02	6
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	ead74453-dd15-4836-8ad6-5b14ac168d02	6
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	ead74453-dd15-4836-8ad6-5b14ac168d02	6
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	ead74453-dd15-4836-8ad6-5b14ac168d02	6
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	973a9333-fec7-46dd-8eb5-25738f06ee54	2
351297	insulin aspart protamine / insulin aspart 70/30 Injectable Suspension	PSN	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977842	NovoLOG Mix 70/30 Injectable Suspension	PSN	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977842	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]	SBD	973a9333-fec7-46dd-8eb5-25738f06ee54	2
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	973a9333-fec7-46dd-8eb5-25738f06ee54	2
351297	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension	SCD	973a9333-fec7-46dd-8eb5-25738f06ee54	2
351297	insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension	SY	973a9333-fec7-46dd-8eb5-25738f06ee54	2
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977842	NovoLog Mix 70/30 Injectable Suspension	SY	973a9333-fec7-46dd-8eb5-25738f06ee54	2
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	973a9333-fec7-46dd-8eb5-25738f06ee54	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0169-3696-19	00169369619	5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) / 3 mL in 1 SYRINGE, PLASTIC		2002-09-11	0000-00-00	No	No	Current
0169-3696-90	00169369690	3 mL in 1 SYRINGE, PLASTIC	3 ml					Historical
0169-3696-97	00169369697	1 in 1 CARTON						Historical
0169-3696-98	00169369698	1 SYRINGE, PLASTIC in 1 CARTON (0169-3696-98) > 3 mL in 1 SYRINGE, PLASTIC (0169-3696-90)		2002-09-11	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
NovoLog Mix 70/30	REMEDYREPACK INC.	2026-05-18	HUMAN PRESCRIPTION DRUG LABEL	14
NovoLog Mix 70/30	A-S Medication Solutions	2026-01-29	HUMAN PRESCRIPTION DRUG LABEL	32
NOVOLOG MIX 70/30	A-S Medication Solutions	2024-01-24	HUMAN PRESCRIPTION DRUG LABEL	6
NovoLog Mix 70/30	Novo Nordisk	2023-02-28	HUMAN PRESCRIPTION DRUG LABEL	24
NovoLog Mix 70/30	Physicians Total Care, Inc.	2010-11-08	HUMAN PRESCRIPTION DRUG LABEL	2